- Home
- CTOR vs MGRM Comparison
CTOR vs MGRM Comparison
Compare CTOR & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOR
- MGRM
- Stock Information
- Founded
- CTOR 2021
- MGRM 2016
- Country
- CTOR United States
- MGRM United States
- Employees
- CTOR N/A
- MGRM N/A
- Industry
- CTOR
- MGRM Medical/Dental Instruments
- Sector
- CTOR
- MGRM Health Care
- Exchange
- CTOR NYSE
- MGRM Nasdaq
- Market Cap
- CTOR 89.9M
- MGRM 89.6M
- IPO Year
- CTOR N/A
- MGRM N/A
- Fundamental
- Price
- CTOR $1.23
- MGRM $2.68
- Analyst Decision
- CTOR Strong Buy
- MGRM Strong Buy
- Analyst Count
- CTOR 2
- MGRM 1
- Target Price
- CTOR $4.50
- MGRM $4.00
- AVG Volume (30 Days)
- CTOR 78.9K
- MGRM 32.1K
- Earning Date
- CTOR 02-21-2025
- MGRM 03-14-2025
- Dividend Yield
- CTOR N/A
- MGRM N/A
- EPS Growth
- CTOR N/A
- MGRM N/A
- EPS
- CTOR N/A
- MGRM N/A
- Revenue
- CTOR N/A
- MGRM $364,999.00
- Revenue This Year
- CTOR N/A
- MGRM N/A
- Revenue Next Year
- CTOR N/A
- MGRM N/A
- P/E Ratio
- CTOR N/A
- MGRM N/A
- Revenue Growth
- CTOR N/A
- MGRM N/A
- 52 Week Low
- CTOR $0.85
- MGRM $1.53
- 52 Week High
- CTOR $49.00
- MGRM $4.90
- Technical
- Relative Strength Index (RSI)
- CTOR N/A
- MGRM 48.75
- Support Level
- CTOR N/A
- MGRM $2.66
- Resistance Level
- CTOR N/A
- MGRM $2.85
- Average True Range (ATR)
- CTOR 0.00
- MGRM 0.13
- MACD
- CTOR 0.00
- MGRM -0.01
- Stochastic Oscillator
- CTOR 0.00
- MGRM 21.43
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.